Post-traumatic stress disorder

goodblend™ Texas Announces Educational goodblend CannaBus™ Tour Across Texas

Retrieved on: 
Wednesday, October 6, 2021
News, Post-traumatic stress disorder, Insomnia, Inflammation, Cancer, Patient, Q&A, Awareness, Cannabis, Spasm, PTSD, Anxiety, Education, Drug, Hospital, Pharmaceutical industry

This goodblend CannaBus tour follows Texas House Bill 1535, which significantly expanded access to the Texas Compassionate Use Program (TCUP, Program) by adding Post-Traumatic Stress Disorder (PTSD) and all forms of cancer to the list of qualifying conditions.

Key Points: 
  • This goodblend CannaBus tour follows Texas House Bill 1535, which significantly expanded access to the Texas Compassionate Use Program (TCUP, Program) by adding Post-Traumatic Stress Disorder (PTSD) and all forms of cancer to the list of qualifying conditions.
  • "We aim to help bridge this gap through Texas' first goodblend CannaBus tour for education and awareness.
  • The goodblend CannaBus dispensary is a retrofitted 36 foot vehicle that is designed with a physician consultation room and an on-board cannabis dispensary featuring goodblend Texas' broad portfolio of innovative product offerings.
  • Should they meet the criteria for the Program, the physician will write a prescription that can be filled immediately in the on-board goodblend CannaBus dispensary.

Freespira Welcomes Three New Executives to Fuel Continued Growth, Build on Proven Success, and Lead Expansion in Key Markets

Retrieved on: 
Tuesday, October 5, 2021
Insurance, Carbon dioxide, Veteran, Hypersensitivity, Federation, Telehealth, FDA, Patient, Administration, Shawn, Panic disorder, Marketing, Fritz Bultman, Consultant, CEO, McMullen, Growth, Respiration, Awareness, Leadership, Tuskegee Veterans Administration Medical Center, Post-traumatic stress disorder, PTSD, Lists of Palestinian rocket attacks on Israel, Quality of life, Population health, U.S. federal government response to the COVID-19 pandemic, Government, Anxiety, CO2, Deepak Chopra, Pharmaceutical industry, Management, Health insurance

Camille McMullen joined Freespira as director of government accounts, focused on managing and overseeing Freespira'sfederalsales operations andensuring continuousengagement withfederalaccounts and key stakeholders to bring this new option to more veterans in need.

Key Points: 
  • Camille McMullen joined Freespira as director of government accounts, focused on managing and overseeing Freespira'sfederalsales operations andensuring continuousengagement withfederalaccounts and key stakeholders to bring this new option to more veterans in need.
  • "2021 has been an exciting year for Freespira as we continue to grow our health plan client base and reach more patients with our life-changing digital therapeutic," said Dean Sawyer, CEO of Freespira.
  • McMullen also brings impressive experience to Freespira with more than 12 years of experience working with the Federal Government.
  • Freespira is transforming the treatment of panic disorder and PTSD by addressing the underlying physiological cause of these conditions.

Tampa General Hospital and Home Base Partner to Offer a Free Health and Fitness Program to Tampa Bay Area Veterans

Retrieved on: 
Monday, October 4, 2021
Trauma, MacDill Air Force Base, Population, Diathesis–stress model, Program, Military sexual trauma, Boston Navy Yard, Artificial intelligence, Exercise, TGH, Health, Depression, United States Marine Corps, National Center of Excellence for Aviation Operators, Adult, Tampa General Hospital, CEO, United States Special Operations Command, Homebase, PTSD, Hospital, U.S. News & World Report, Anxiety, Traumatic brain injury, Partnership, Fitness, Woman, Forbes, Veteran, Fast Track, Home, Life, Plague, Veterans' affairs, GE Healthcare, Massachusetts General Hospital, Education, Home-based program, News, Patient, National Center for Telehealth & Technology, Post-traumatic stress disorder, Research, Tic disorder, State, Medicine

Tampa General Hospital and Home Base, a Red Sox Foundation and Massachusetts General Hospital program, are forming a partnership to create a free health and fitness program.

Key Points: 
  • Tampa General Hospital and Home Base, a Red Sox Foundation and Massachusetts General Hospital program, are forming a partnership to create a free health and fitness program.
  • The Home Base Warrior Health & Fitness program will be based at the TGH Fitness Center located on the hospital's main campus and led by trained fitness specialists.
  • The partnership to bring the Home Base Warrior Health & Fitness program to Tampa Bay will combine Home Base's outreach and programing expertise while leveraging TGH's existing wellness and clinical platform to provide meaningful services to veterans.
  • Participants in the Home Base Warrior Health and Fitness program at Tampa General receive:
    "Home Base was founded to heal the invisible wounds carried by veterans," said Armando Hernandez, program director, Home Base SWFL and U.S. Marine veteran.

Ascellus Announces Publication of Study in Journal of Occupational and Environmental Medicine Citing Improved Outcomes for Work-related Concussions

Retrieved on: 
Monday, October 4, 2021
Professional Services, Mental Health, Health, Other Health, Human Resources, General Health, Pain management, Concussion, Health, Mental health, JOEM, Program, Journal of Occupational and Environmental Medicine, Environmental medicine, Journal, COVID-19, Technology, Post-traumatic stress disorder, NCSE, Research, Job, PTSD, Medicine

The study demonstrates the positive effects of the Companys neurocognitive screening evaluation (NCSE) and brief therapy model in realizing improved recovery and return-to-work outcomes for work-related concussions.

Key Points: 
  • The study demonstrates the positive effects of the Companys neurocognitive screening evaluation (NCSE) and brief therapy model in realizing improved recovery and return-to-work outcomes for work-related concussions.
  • The study, published in the latest issue of JOEM is titled, Improving Outcomes for Work-Related Concussions: A Mental Health Screening and Brief Therapy Model .
  • It included 157 injured workers who had previously suffered work-related concussions and engaged in treatment from March 2019 to March 2021.
  • Ascellus provides evidence-based treatment for pain management, workplace trauma, post-traumatic stress disorder (PTSD), head injury/mTBI, COVID-19, and California Stress Claims.

Addex to Present at the 10th International Meeting on Metabotropic Glutamate Receptors

Retrieved on: 
Monday, October 4, 2021
Therapy, Clinical trial, Neurodegeneration, Janssen Pharmaceuticals, Epilepsy, Discovery, Metabotropic glutamate receptor 3, Biology, PAM, Dyskinesia, International Meeting for Autism Research, SIX Swiss Exchange, Private Securities Litigation Reform Act, Nasdaq, Glutamate (neurotransmitter), American depositary receipt, Allosteric regulation, NAM, Dystonia, Glutamic acid, Blepharospasm, ADX71149, Post-traumatic stress disorder, Chemistry, Drug discovery, PTSD, Glutamate receptor, GABAB, SEC, Protein, Lists of diseases, L-DOPA, Risk management, Pharmaceutical industry

Addex Therapeutics explicitly disclaims any obligation to update any forward-looking statements.

Key Points: 
  • Addex Therapeutics explicitly disclaims any obligation to update any forward-looking statements.
  • Geneva, Switzerland, October 4, 2021- Addex Therapeutics (SIX: ADXN), a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, announced today that Dr Robert Ltjens, Head of Discovery Biology and Dr Jean-Philippe Rocher, Head of Discovery Chemistry, will present at the 10th International Meeting on Metabotropic Glutamate Receptors (October 1 - 6, 2021).
  • For more information or to schedule a one-on-one meeting with management, please contact us at [email protected] .
  • Addex's allosteric modulator drug discovery platform targets receptors and other proteins that are recognized as essential for therapeutic intervention.

Global Psychedelic Drugs Market Review and Outlook, 2021 | Featuring Profiles of Jazz Pharma, PharmaTher Holdings, ATAI LIFE SCIENCES, COMPASS Pathways, Mind Medicine, and Janssen Pharma - ResearchAndMarkets.com

Retrieved on: 
Friday, October 1, 2021
Pharmaceutical, Health, Mental Health, Adoption, Social anxiety, Mouse, Janssen Pharmaceuticals, Harvard University, Food, Ketamine, Mental, WHO, Depression, LSD, Yale University, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, CAGR, FDA, OCD, World Health Organization, MDMA, MDD, Tic disorder, The New England Journal of Medicine, TRD, Grammatical mood, Prevalence, Growth, World, COVID-19, Post-traumatic stress disorder, Cognition, Psychiatry, Mental disorder, NCBI, Lists of diseases, Brain, Suicidal ideation, Psychotherapy, Psilocybin, US, Pet, Pharmaceutical industry

The "Psychedelic Drugs Market - Global Industry Analysis (2018-2020) - Growth Trends and Market Forecast (2021-2026)" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Psychedelic Drugs Market - Global Industry Analysis (2018-2020) - Growth Trends and Market Forecast (2021-2026)" report has been added to ResearchAndMarkets.com's offering.
  • However, synthetic products will maintain their dominant market position with an 85% market share in 2026.
  • Depression is estimated to hold the largest chunk of the disease indication segment with more than 40% market share in 2021.
  • Ketamine is on track to record the highest CAGR in the psychedelic drugs market as it has been used for decades.

Hoag Opens Center for Advanced Visualization and Immersive Therapeutics

Retrieved on: 
Friday, October 1, 2021
DNV, Therapy, Human skull symbolism, U.S. News & World Report, Brain, Addiction medicine, US Global Development Lab, Transport, Patient, Virtual reality, Aneurysm, National Association of Epilepsy Centers, Hoag (health network), Center, No, Pain, AR, Mental health, Augmented reality, ANCC, Health, Stroke, American Heart Association, Multimedia, Pathology, Movement disorders, Physician, American Nurses Credentialing Center, Heart, Phobia, Neuro, Technology, Anatomy, Spine, Neuroscience, Elective surgery, Epilepsy, National Association, Memory, Cancer, Physiology, Hospital, Journal of Neurology, Neurosurgery, and Psychiatry, Multiple sclerosis, Education, XR, AFI's 10 Top 10, News, Pectus carinatum, VR, Nursing, Lists of diseases, Post-traumatic stress disorder, Research, Medicine

NEWPORT BEACH, Calif., Oct. 1, 2021 /PRNewswire/ --Already a nationally recognized leader in Experiential Reality (XR) technology, Hoag Memorial Hospital Presbyterian today announced the opening of the new Hoag Center for Advanced Visualization and Immersive Therapeutics inside Hoag's Pickup Family Neurosciences Institute Newport Beach campus.

Key Points: 
  • NEWPORT BEACH, Calif., Oct. 1, 2021 /PRNewswire/ --Already a nationally recognized leader in Experiential Reality (XR) technology, Hoag Memorial Hospital Presbyterian today announced the opening of the new Hoag Center for Advanced Visualization and Immersive Therapeutics inside Hoag's Pickup Family Neurosciences Institute Newport Beach campus.
  • Hoag will host the 2nd Annual Hoag Advances in Clinical Virtual Reality Symposium on Friday, October 1, 2021.
  • A preview of the new Hoag Center for Advanced Visualization and Immersive Therapeutics will be presented at this symposium.
  • Hoag has been recognized as a designated Level 4 Comprehensive Epilepsy Center by the National Association of Epilepsy Centers.

Seelos Therapeutics to Present a Poster on SLS-002 (Intranasal Racemic Ketamine) at the 2021 IASR/AFSP International Summit on Suicide Research

Retrieved on: 
Friday, October 1, 2021
EDT, CNS, Post-traumatic stress disorder, Therapy, Ketamine, Nature, National Suicide Prevention Lifeline, Risk, Major depressive disorder, Annual report, Agency for Healthcare Research and Quality, Conference, Private Securities Litigation Reform Act, National Suicide Prevention Week, Depression, Sanfilippo syndrome, U.S. Securities and Exchange Commission, Patient, Movement disorders, ASIB, Poster, Disorder, Central nervous system, Degenerative disease, MDD, Disease, CEO, Parkinson's disease, Company, Program, Lists of diseases, Agency, Trial of the century, Amyotrophic lateral sclerosis, COVID-19, ALS, Research, Psychiatry, PTSD, Imminent Risk, Nasdaq, IASR, Pharmaceutical industry

If you or a loved one are having thoughts of suicide, please seek immediate medical help, go to your nearest emergency room, or call the National Suicide Prevention Lifeline at 1-800-273-8255.

Key Points: 
  • If you or a loved one are having thoughts of suicide, please seek immediate medical help, go to your nearest emergency room, or call the National Suicide Prevention Lifeline at 1-800-273-8255.
  • SLS-002is intranasal racemic ketamine with two investigational new drug applications ("INDs").
  • SLS-002 was originally derived from a Javelin Pharmaceuticals, Inc./Hospira, Inc. program with 16 clinical studies involving approximately 500 subjects.
  • SLS-002 looks to address an unmet need for an efficacious drug to treat suicidality in the United States.

Virpax to Present at the NobleCon Online Pain Management Investor Forum on Channelchek.com on October 7, 2021

Retrieved on: 
Friday, October 1, 2021
Biotechnology, Pharmaceutical, Health, Clinical Trials, CNS, Nature, Securities Act of 1933, Chronic pain, CBD, Epilepsy, Noble, Research, Security (finance), Pain management, Central nervous system disease, Investor, NASDAQ, U.S. Securities and Exchange Commission, FDA, Cancer, Capital market, FREE, Ariad Pharmaceuticals, Inc. v. Eli Lilly & Co., Osteoarthritis, Private Securities Litigation Reform Act, Bupivacaine, Industry, Company, MET, Pain, FINRA, COVID-19, Post-traumatic stress disorder, Severe acute respiratory syndrome coronavirus 2, PTSD, Securities Exchange Act of 1934, SEC, Pharmaceutical industry, Risk management, Virpax Pharmaceuticals, Noble Capital Markets, Inc., Channelchek, VIRPAX PHARMACEUTICALS, NOBLE CAPITAL MARKETS, INC., CHANNELCHEK

The presentation can be accessed by registering (at no cost) for the Investor Forum at www.channelchek.com ; the investor portal created by Noble.

Key Points: 
  • The presentation can be accessed by registering (at no cost) for the Investor Forum at www.channelchek.com ; the investor portal created by Noble.
  • Additionally, a video webcast of the presentation will be available beginning October 7, 2021 on the Investors section of the Virpax Pharmaceuticals website at https://ir.virpaxpharma.com/ .
  • Virpax is developing branded, non-addictive pain management and neurological product candidates using its proprietary technologies to optimize and target drug delivery.
  • Envelta is an intranasal molecular-envelope enkephalin formulation being developed to manage acute and chronic pain, including pain associated with cancer.

Cross-Platform Evaluation of Commercial Metabolomics Platforms to Support Precision Therapeutics Research

Retrieved on: 
Thursday, September 30, 2021
Therapy, Partnership, Foundation for Innovative New Diagnostics, Neurological disorder, Biomedical Research, Research, AIDS Research Alliance, Diagnosis, IARC, Stanford University School of Medicine, MD, Metabolomics, Biomarker, Method, CEO, TBI, DOI, Disease, Paper, Technology, Post-traumatic stress disorder, Industry, Innovation, PTSD, Max Planck Institute of Psychiatry, Doctor of Philosophy, Proteomics, Organic, Max Planck Society, Medical device, Medical imaging, Pharmaceutical industry

The findings, published online September 8th in Metabolites (DOI: 10.3390/metabo11090609), investigate coverage across metabolite classes and relative accuracy and precision of the platforms.

Key Points: 
  • The findings, published online September 8th in Metabolites (DOI: 10.3390/metabo11090609), investigate coverage across metabolite classes and relative accuracy and precision of the platforms.
  • The study also evaluated the specific utility of these metabolomic platforms for analysis of metabolites implicated in post-traumatic stress disorder (PTSD) research.
  • Accurate and standardized measurement platforms are important tools to advance biomarker research, understand disease mechanisms, and assist in identifying therapeutic targets.
  • Cohen Veterans Bioscience is a non-profit 501(c)(3) biomedical research and technology organizationdedicated to advancing brain healthby fast-tracking precision diagnostics and tailored therapeutics.